Vivos Therapeutics, Inc.
VVOS
$2.57
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.62M | -1.93M | -3.76M | -4.26M | -2.09M |
| Total Depreciation and Amortization | 146.00K | 145.00K | 146.00K | 149.00K | 149.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 148.00K | 295.00K | 299.00K | 456.00K | -1.57M |
| Change in Net Operating Assets | -1.86M | -1.56M | 802.00K | 906.00K | 713.00K |
| Cash from Operations | -4.19M | -3.05M | -2.52M | -2.75M | -2.80M |
| Capital Expenditure | -192.00K | -60.00K | -151.00K | -165.00K | -154.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -192.00K | -60.00K | -151.00K | -165.00K | -154.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.30M | 7.50M | 3.94M | 4.00M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -509.00K | -100.00K | -306.00K | -432.00K | 0.00 |
| Cash from Financing | 3.79M | 7.40M | 3.64M | 3.57M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -592.00K | 4.29M | 968.00K | 655.00K | -2.95M |
